Logo image of EBUS.AS

EBUSCO HOLDING NV (EBUS.AS) Stock Fundamental Analysis

AMS:EBUS - Euronext Amsterdam - NL0015002AG2 - Common Stock - Currency: EUR

0.423  +0 (+1%)

Fundamental Rating

2

EBUS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 109 industry peers in the Machinery industry. EBUS may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, EBUS is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

EBUS had negative earnings in the past year.
In the past year EBUS has reported a negative cash flow from operations.
EBUS had negative earnings in 4 of the past 5 years.
EBUS had a negative operating cash flow in each of the past 5 years.
EBUS.AS Yearly Net Income VS EBIT VS OCF VS FCFEBUS.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M -200M

1.2 Ratios

The Return On Assets of EBUS (-50.80%) is worse than 92.66% of its industry peers.
EBUS has a Return On Equity of -120.90%. This is amonst the worse of the industry: EBUS underperforms 88.99% of its industry peers.
Industry RankSector Rank
ROA -50.8%
ROE -120.9%
ROIC N/A
ROA(3y)-52.86%
ROA(5y)-30.11%
ROE(3y)-269.12%
ROE(5y)-151.33%
ROIC(3y)N/A
ROIC(5y)N/A
EBUS.AS Yearly ROA, ROE, ROICEBUS.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for EBUS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EBUS.AS Yearly Profit, Operating, Gross MarginsEBUS.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

More info and screens

2

2. Health

2.1 Basic Checks

EBUS does not have a ROIC to compare to the WACC, probably because it is not profitable.
EBUS has more shares outstanding than it did 1 year ago.
EBUS has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, EBUS has a worse debt to assets ratio.
EBUS.AS Yearly Shares OutstandingEBUS.AS Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
EBUS.AS Yearly Total Debt VS Total AssetsEBUS.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

EBUS has an Altman-Z score of -1.93. This is a bad value and indicates that EBUS is not financially healthy and even has some risk of bankruptcy.
EBUS has a Altman-Z score of -1.93. This is in the lower half of the industry: EBUS underperforms 77.98% of its industry peers.
A Debt/Equity ratio of 0.11 indicates that EBUS is not too dependend on debt financing.
EBUS has a Debt to Equity ratio of 0.11. This is amongst the best in the industry. EBUS outperforms 84.40% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z -1.93
ROIC/WACCN/A
WACC6.42%
EBUS.AS Yearly LT Debt VS Equity VS FCFEBUS.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

A Current Ratio of 1.30 indicates that EBUS should not have too much problems paying its short term obligations.
EBUS has a Current ratio of 1.30. This is in the lower half of the industry: EBUS underperforms 66.06% of its industry peers.
EBUS has a Quick Ratio of 1.30. This is a bad value and indicates that EBUS is not financially healthy enough and could expect problems in meeting its short term obligations.
EBUS has a Quick ratio of 0.56. This is amonst the worse of the industry: EBUS underperforms 86.24% of its industry peers.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 0.56
EBUS.AS Yearly Current Assets VS Current LiabilitesEBUS.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for EBUS have decreased strongly by -224.81% in the last year.
The Revenue for EBUS has decreased by -15.07% in the past year. This is quite bad
The Revenue for EBUS have been decreasing by -26.26% on average. This is quite bad
EPS 1Y (TTM)-224.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-65%
Revenue 1Y (TTM)-15.07%
Revenue growth 3Y-23.97%
Revenue growth 5Y-26.26%
Sales Q2Q%-8.91%

3.2 Future

EBUS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.19% yearly.
EBUS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 55.57% yearly.
EPS Next Y61.82%
EPS Next 2Y45.44%
EPS Next 3Y37.63%
EPS Next 5Y18.19%
Revenue Next Year23.69%
Revenue Next 2Y77.67%
Revenue Next 3Y84.07%
Revenue Next 5Y55.57%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EBUS.AS Yearly Revenue VS EstimatesEBUS.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M 1B
EBUS.AS Yearly EPS VS EstimatesEBUS.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 1 -1 2 -2 -3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EBUS. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EBUS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EBUS.AS Price Earnings VS Forward Price EarningsEBUS.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EBUS.AS Per share dataEBUS.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4

4.3 Compensation for Growth

A more expensive valuation may be justified as EBUS's earnings are expected to grow with 37.63% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.44%
EPS Next 3Y37.63%

More info and screens

0

5. Dividend

5.1 Amount

EBUS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EBUSCO HOLDING NV

AMS:EBUS (6/4/2025, 7:00:00 PM)

0.423

+0 (+1%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners18.96%
Inst Owner ChangeN/A
Ins Owners17.25%
Ins Owner ChangeN/A
Market Cap29.78M
Analysts38
Price Target1.54 (264.07%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-142.3%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-35.02%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.3
P/FCF N/A
P/OCF N/A
P/B 0.24
P/tB 0.41
EV/EBITDA N/A
EPS(TTM)-5.18
EYN/A
EPS(NY)-1.39
Fwd EYN/A
FCF(TTM)-1.43
FCFYN/A
OCF(TTM)-1.25
OCFYN/A
SpS1.4
BVpS1.74
TBVpS1.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -50.8%
ROE -120.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-52.86%
ROA(5y)-30.11%
ROE(3y)-269.12%
ROE(5y)-151.33%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 142.11%
Cap/Sales 13.11%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.3
Quick Ratio 0.56
Altman-Z -1.93
F-Score1
WACC6.42%
ROIC/WACCN/A
Cap/Depr(3y)120.22%
Cap/Depr(5y)113.35%
Cap/Sales(3y)55.38%
Cap/Sales(5y)38.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-224.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-65%
EPS Next Y61.82%
EPS Next 2Y45.44%
EPS Next 3Y37.63%
EPS Next 5Y18.19%
Revenue 1Y (TTM)-15.07%
Revenue growth 3Y-23.97%
Revenue growth 5Y-26.26%
Sales Q2Q%-8.91%
Revenue Next Year23.69%
Revenue Next 2Y77.67%
Revenue Next 3Y84.07%
Revenue Next 5Y55.57%
EBIT growth 1Y-76.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year52.94%
EBIT Next 3Y44.61%
EBIT Next 5Y29.68%
FCF growth 1Y1.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4.04%
OCF growth 3YN/A
OCF growth 5YN/A